Epopromycin B is a macrolide antibiotic that is derived from the fermentation of certain Streptomyces species. It is characterized by its large lactone ring structure, which is typical of macrolides, contributing to its biological activity. Epopromycin B exhibits antibacterial properties, particularly against Gram-positive bacteria, by inhibiting protein synthesis through binding to the 50S ribosomal subunit. This mechanism of action is similar to that of other macrolides, such as erythromycin. The compound is known for its potential therapeutic applications, although its clinical use may be limited compared to more widely used antibiotics. Epopromycin B has a specific molecular formula and structure that contribute to its solubility and stability under various conditions. Its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are important for understanding its efficacy and safety profile. As with many antibiotics, resistance can develop, making ongoing research into its effectiveness and potential modifications essential for maintaining its utility in treating bacterial infections.

epopromycin B

153540-56-8: Epopromycin B is a macrolide antibiotic that is derived from the fermentation of certain Streptomyces species. It is characterized by its large lactone ring structure, which is typical of macrolides, contributing to its biological activity. Epopromycin B exhibits antibacterial properties, particularly against Gram-positive bacteria, by inhibiting protein synthesis through binding to the 50S ribosomal subunit. This mechanism of action is similar to that of other macrolides, such as erythromycin. The compound is known for its potential therapeutic applications, although its clinical use may be limited compared to more widely used antibiotics. Epopromycin B has a specific molecular formula and structure that contribute to its solubility and stability under various conditions. Its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are important for understanding its efficacy and safety profile. As with many antibiotics, resistance can develop, making ongoing research into its effectiveness and potential modifications essential for maintaining its utility in treating bacterial infections.

Epopromycin B inhibits cell wall synthesis in lettuce protoplasts, demonstrating herbicidal activity. It also exhibits cytotoxicity in B16 melanoma cells, with an IC50 of 0.003 µg/mL.

CAS 153540-56-8

epopromycin B

Epopromycin B

Ref: TM-TN10539